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Edited by Stuart FergusonAbstract Cerebral ischemia is known to activate endogenous
neural stem cells (NSCs), but its mechanisms remain unknown.
Since lowered glucose supply seems to mediate ischemic actions,
we examined the eﬀect of low glucose on NSC activities in vitro.
Low glucose applied during the proliferation period diminished
EGF-induced proliferation of NSCs without aﬀecting subsequent
diﬀerentiation, but low glucose directly exposed during the
diﬀerentiation period facilitated the diﬀerentiation of NSCs into
neurons and astrocytes. These ﬁndings suggest that low glucose
facilitated NSC diﬀerentiation, but it diminished NSC prolifer-
ation. Moreover, the eﬀect of low glucose may be dependent on
the timing of application.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Advance in neuroscience has led to a new understanding of
the development and cell-lineage of mammalian brain cells
and has revealed that neurons and glial cells are derived from
common immature precursor cells called neural stem cells
(NSCs) [1,2]. NSCs are deﬁned as self-renewal and multipo-
tential cells and have been recently found to exist not only
in the developing brain, but also in the matured brain in
mammals [3].
Cerebral ischemia is generally known to elicit a complex
cascade of cellular events, leading to both acute and delayed
death of a subset population of neurons in the central nervous
system and severe brain functions in animal models as well as
human beings [4]. Interestingly, recent lines of evidence have
demonstrated that global and focal ischemia enhances the
proliferation and neural diﬀerentiation of endogenous NSCs
not only in continually neurogenic regions, such as the dentate* Corresponding author. Fax: +81-95-849-7036.
E-mail address: kazuyuki@net.nagasaki-u.ac.jp (K. Shinohara).
Abbreviations: NSCs, neural stem cells; DMEM, Dulbecco’s modiﬁed
Eagle’s medium; BrdU, bromodeoxyuridine
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where neurogenesis normally does not occur, such as the
hippocampal CA1 area [11]. Nevertheless, the mechanism
underlying ischemia-induced NSC activation has not been
fully understood.
Among various incidents during ischemia, reductions in the
supply of oxygen (hypoxia) and glucose (hypoglycemia) in the
brain seem to be the main factors mediating ischemic brain
damage. In response to hypoxia and hypoglycemia, however,
neurons show diﬀerent responses such as synaptic transmis-
sions [12], neuronal death patterns [13] and gene expressions
[14]. Recently, several studies have demonstrated that hypoxia
enhances the proliferation of cultured NSCs and modiﬁes their
diﬀerentiative ability [15–17], whereas there have been no re-
ports which examined the eﬀect of hypoglycemia on the NSCs
or progenitor cells. It is generally known that external glucose
from plasma is the only fuel available in the central nervous
system and that ischemia rapidly decreases the brain glucose
concentration, which leads to various pathological events such
as neuronal loss in the models both in vivo and in vitro [18].
Furthermore, the proliferation and diﬀerentiation of certain
types of cells, such as hepatic oval cells and pancreatic b cells,
have been proved to be dependent on the glucose concentra-
tion [19–21]. Therefore, to elucidate the mechanism underlying
the ischemia-induced NSC activation, we tried to examine the
eﬀect of the glucose concentration on the proliferation and
diﬀerentiation of NSCs by means of an in vitro NSC culture
system, since the in vitro system can control the glucose con-
centrations and delineate the actions of extrinsic factors. Be-
cause cerebral ischemia has been reported to change the brain
glucose concentration ranging from 0 and to 10 mM [22], we
investigated the eﬀect of glucose concentrations at 0, 3 and 10
mM. We also examined the eﬀect of 36.4 mM glucose, the
concentration of which is higher than the physiological glucose
concentration in vivo but is used in traditional standard NSC
cultures [23]. In addition, we also determined whether the ef-
fects of the glucose concentration are dependent on the timing
of exposure, the proliferation or the diﬀerentiation period.
Here, we show that low glucose incubations during the pro-
liferation period drastically suppressed the proliferation of
NSCs, but that low glucose incubations during the diﬀerenti-
ation period increased the diﬀerentiation into neurons and
astrocytes from NSCs.ation of European Biochemical Societies.
238 N. Horie et al. / FEBS Letters 571 (2004) 237–2422. Materials and methods
2.1. Primary NSC culture
The NSCs were isolated and propagated by a neurosphere method
developed by Reynolds et al. [24]. ICR mouse fetuses on embryonic
day 15.5 (midnight of overnight mating is designated as embryonic day
0) were isolated from their mother under deep anesthesia with ether
and placed into ice-cold 1:1 mixture of Dulbecco’s modiﬁed Eagle’s
medium and F-12 nutrient (DMEM/F-12; Gibco-BRL, Gaithersburg,
Md., USA). The ganglionic eminence tissues were carefully micro-
dissected under a stereomicroscope and triturated with a commercial 1
ml plastic pipette to obtain a single cell suspension in N-2 medium
(DMEM/F-12 supplemented with 36.4 mM glucose, 23 lg/ml insulin,
92 lg/ml transferrin, 55 lM putrescine, 27.5 nM sodium selenite, 20
nM progesterone and 50 U/ml penicillin–streptomycin) [23]. The viable
dissociated cells at a density of 25 104 cells/5 ml in N-2 medium
containing 20 ng/ml EGF (Invitrogen Corp., Carlsbad, CA, USA)
were seeded into uncoated T25 culture ﬂasks (Becton–Dickinson,
Franklin Lakes, NJ) and were maintained in a humidiﬁed incubator at
37 C with 95% atmospheric air/5% CO2. Cultures were fed with 1.25
ml of fresh medium every other day and were kept incubated for 7 days
to form enough primary neurospheres.
2.2. Experimental procedure
The eﬀects of the glucose concentration on the proliferative activity
of the NSCs were evaluated by three methods; (1) WST-8 assay [25],
(2) the bromodeoxyuridine (BrdU) incorporation assay [25] and (3) the
counting of neurospheres [16]. The single cell suspensions from pri-
mary neurospheres were prepared by a centrifugation (1200 rpm, 5
min) followed by a mechanical dissociation. They were seeded in the
N-2 medium containing EGF (20 ng/ml) with various concentrations
of glucose (0, 3, 10 or 36.4 mM) in a non-treated 96-well plate (Becton–
Dickinson). Thereafter, the viable cell number, BrdU incorporation
and the number of secondary neurospheres were measured on an ap-
propriate day.
The eﬀects of the glucose concentration on the diﬀerentiation of the
NSCs were evaluated by ﬂuorescence-based immunocytochemistry and
ELISA [26]. In addition, we discriminated the timing of exposure to
hypoglycemia (the proliferation or diﬀerentiation period), since a
previous report noted that a facilitative action of hypoxia on NSC
diﬀerentiation depended on the timing of exposure [16]. Brieﬂy, the
single cell suspensions from primary neurospheres were re-expanded in
the N-2 medium containing EGF with various concentrations of glu-
cose (0, 3, 10 or 36.4 mM) in a T25 culture ﬂask. The resultant sec-
ondary neurospheres were mechanically dissociated and then
diﬀerentiated for 7 days in the presence of 36.4 mM glucose by incu-
bation in 1% FBS-containing N-2 medium lacking EGF on a Lab-
Tek Chamber SlideTM (Nunc, Inc., Naperville, IL, USA) pre-coated
with 0.005% poly-L-ornithine (Sigma, St. Louis, MO, USA) for im-
munocytochemistry or in a 96-well plate (Becton–Dickinson) pre-
coated with 0.0025% poly-L-ornithine for ELISA. On the other hand,
the single cell suspensions from primary neurospheres formed in 36.4
mM glucose-containing medium were mechanically dissociated and
diﬀerentiated for 7 days in the N-2 medium lacking EGF at various
concentrations of glucose (0, 3, 10 or 36.4 mM), and the diﬀerentiative
activity was evaluated by the same method as described above. We
changed the mannose concentrations to keep the osmotic pressure of
the culture medium at various glucose concentrations constant. We
monitored the glucose level during the proliferation and diﬀerentiation
period using GLUTESTACE R (SANWA KAGAKU KENKYU-
SHO CO., LTD, Nagoya, Japan), because it is possible that glucose
level is decreased during experiments. During the proliferation period,
actual glucose levels of 36.4, 10, 3 and 0 mM were measured to be 36.6,
11.4, 2.7 and 0 mM at the beginning of the experiment and 33.3, 10.8,
2.5 and 0 mM on 5th day, respectively. During the diﬀerentiation
period, actual glucose levels of 36.4, 10, 3 and 0 mM were measured to
be 36.3, 10.9, 2.4 and 0 mM at the beginning of the experiment and
33.6, 9.9, 2.2 and 0 mM on 7th day, respectively. Thus, the change in
glucose level was not signiﬁcant.
2.3. WST-8 assay
The number of the viable cells was estimated by WST-8 assay with
Cell Counting Kit-SF (Tesque Nacalai, Kyoto, Japan). WST-8 (2-(2-
methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium, monosodium salt) is metabolized by the mitochondrialenzyme NAD-dependent succinate dehydrogenase to form a colored
formazan product [27–29]. The amount of formazan dye generated by
the activity of the dehydrogenases in cells is known to be directly
proportional to the number of living cells.
Brieﬂy, the single cell suspensions of EGF-expanded NSCs were
seeded in a non-treated 96-well plate (Becton–Dickinson) at a cell
density of 5000 cells per well. After 1, 2, 3, 4 and 5 day incubation at
various concentrations of glucose, 5 ll of the Cell Counting Kit so-
lution was added to each well and incubated for an additional 5 h at 37
C. The absorbance at 450 nm with a reference wavelength of 630 nm
was measured by a microplate reader (Thermo Labsystems, Vantaa,
Finland). By means of these experimental procedures, we obtained a
good linear relationship between the net absorbance and the cell
density (0–15 000 cells per well) (data not shown).
2.4. BrdU incorporation assay
The BrdU incorporation assay was performed with a Cell Prolif-
eration ELISA BrdU kit (Roche, Mannheim, Germany) according to
the manufacturer’s instructions. Brieﬂy, the single cell suspensions of
EGF-expanded NSCs were seeded in a well of a non-treated 96-well
plate (Becton–Dickinson) at a cell density of 5000 cells per well.
After 24 h incubation, the cells were labeled with a 10 lM of BrdU
and incubated for an additional 8 h. After centrifugation at 300· g
for 10 min, the labeling medium was removed by aspiration and the
cells were dried. Thereafter, cellular DNA was denatured by adding
FixDenat solution (Roche) for 30 min at room temperature. After
removal of the FixDenat solution, anti-BrdU antibody conjugated
with peroxidase solution was added to each well and incubated for
90 min at room temperature. After three washes with PBS, tetra-
methylbenzidine (TMB) solution with H2O2 (SUMILON, Tokyo,
Japan) was added to each well and the cells were incubated for
60 min at room temperature. Immediately after stopping the total
reaction by adding 2 N H2SO4 solution, the absorbance at 450 nm
(reference wavelength 630 nm) was measured with a microplate
reader (Thermo Labsystems). By means of these experimental pro-
cedures, we observed a good linear relationship between the net
absorbance and the cell density (0–15 000 cells per well) (data not
shown).
2.5. Neurosphere counting
The single cell suspensions of EGF-expanded NSCs were seeded
in a non-treated well of 96-well plate (Becton–Dickinson) at a cell
density of 5000 cells per well and then incubated for 5 days with
EGF at various concentrations of glucose. A ﬁxed area (10 mm2) of
the center of each well was converted into a digital image with a
digital still camera (DSC-S70, SONY, Tokyo, Japan) and the
number of neurospheres with a diameter of more than 60 lm
was counted with a Scion Image Beta 4.02 (Scion Corporation,
Frederick, MD).
2.6. Immunocytochemistry
The diﬀerentiated cells in a Lab-Tek Chamber SlideTM (Nunc)
were ﬁxed in PBS containing 4% paraformaldehyde for 30 min at
room temperature and they were then permeabilized by incubation
with 100% methanol at )20 C for 10 min. After removal of the
methanol, the cells were incubated overnight with anti-TuJ1 antibody
(1: 200; mouse monoclonal antibody, Sigma) and anti-GFAP anti-
body (1:80; rabbit polyclonal antibody, Sigma) in PBS containing
0.1% Triton X-100 and 3% normal goat serum at 4 C. After removal
of the primary antibody solution, the cells were washed with PBS
three times and were incubated with two secondary antibodies (Alexa
Fluoro 488 goat anti-mouse IgG, 1:200 and Alexa Fluoro 568 goat
anti-rabbit IgG, 1:200, Molecular Probes Inc., Eugene, OR) and
1.25 lg/ml of Hoechst 33258 for a nuclear counter staining for 4 h at
room temperature under light-shading conditions. After sequential
washing with PBS and water, the slides were mounted with Perma-
FluorTM Aqueous Mounting Medium (Thermo Shandon, Pittsburgh,
PA, USA) and their ﬂuorescent images were viewed under a micro-
scope (LSM10, CarlZeiss). For the quantitative analysis, we counted
numbers of TuJ1-positive cells (neurons) and GFAP-positive cells
(astrocytes) in a ﬁxed area (200 200 lm) of the center of each well
under the ﬂuorescent-microscope. The numbers of TuJ1- and GFAP-
positive cells were counted by an observer without knowledge of
treatment condition and were normalized to the total cell number
(Hoechst33258-stained nucleus).
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Cells diﬀerentiated in the well of tissue culture treated 96-well plates
(Becton–Dickinson) were ﬁxed with 4% paraformaldehyde in PBS for
30 min at room temperature and they were then permeabilized by in-
cubation with 100% methanol at )20 C for 10 min. After removal of
the methanol, the cells were incubated with one of the following pri-
mary antibodies in PBS containing 0.1% Triton X-100 and 3% normal
goat serum overnight at 4 C; anti-TuJ1 mouse monoclonal antibody
(1:600, Sigma) or anti-GFAP rabbit polyclonal antibody (1:300, Sig-
ma). After three washes with PBS, the cells were incubated with an
appropriate secondary antibody (goat anti-mouse or anti-rabbit anti-
body conjugated with horseradish peroxidase, CHEMICON, Califor-
nia, USA; 1:7000) for 4 h. After three washes with PBS, cultures were
added to TMB solution with H2O2 (SUMILON) for 60 min at room
temperature. Immediately after terminating the reaction by adding 1N
H2SO4 solution, the absorbance at 450 nm with a reference wavelength
of 630 nm was measured by a microplate reader (Thermo Lab
Systems).
2.8. Statistical analysis
Results are shown as the meansS.E.M. Statistical diﬀerence was
analyzed by one-way ANOVA followed by Dunnett’s test. Results
were considered to be signiﬁcant when the P value was less than
0.05.Fig. 1. Low glucose culture during the proliferation period diminished
the proliferative activity of the NSCs. NSCs dissociated from the
primary neurospheres were cultured at various concentrations of glu-
cose (0, 3, 10 and 36.4 mM) in the presence of EGF. Relative values of
viable NSCs and their DNA synthesis were measured by WST-8 assay
on days 1–5 (A) and BrdU incorporation assay on day 1 (B), respec-
tively. (C) The neurospheres formed under various glucose concen-
trations on day 5. Representative photographs and the numbers of
neurospheres with small (61–80 lm), medium (81–110 lm) and large
(>111 lm) diameters are shown. The continuous culture with low
glucose medium signiﬁcantly produced smaller neurospheres than
those under high glucose medium. The asterisk indicates the signiﬁcant
diﬀerence from high glucose (36.4 mM) (P < 0:05; one-way ANOVA
followed by Dunnett’s test). n ¼ 6.3. Results
3.1. Eﬀect of lower glucose exposure during the proliferation
period on the NSC proliferative activity
The incubation with EGF produced big colonies that were
termed neurospheres. The cell viability for all the primary
cultures examined was over 90% at the beginning of the ex-
periment. As shown in Fig. 1A, the glucose concentration
during the proliferation period did not aﬀect the viable cell
number of NSCs on day 1 and day 2. Exposure to lower glu-
cose during the proliferation period, however, suppressed the
increment in the number of viable cells on days 3, 4 and 5. On
day 5, viable cells in 10 mM glucose medium were approxi-
mately 56% of those in 36.4 mM glucose and the lower glucose
concentrations at 3 and 0 mM further suppressed the NSCs
proliferation to 29% and 23%, respectively. We also found that
the BrdU incorporation was decreased when cultures were
exposed to a lower glucose concentration (Fig. 1B). The degree
of BrdU incorporation at 0, 3 and 10 mM glucose concentra-
tions was 64%, 66% and 81%, respectively (Fig. 1B). Further-
more, we determined whether the glucose concentration aﬀects
the ability to form secondary neurospheres. The continuous
culture at various concentrations of glucose (0, 3 or 10 mM)
signiﬁcantly diminished the number of neurospheres compared
with that at a high concentration of glucose (36.4 mM)
(Fig. 1C).
3.2. Eﬀect of lower glucose exposure during the proliferation
period on the NSC diﬀerentiative activity
We evaluated the diﬀerentiative activity of the NSC, which
had been increased at various glucose concentrations. Single
cells grown at various concentrations of glucose medium (0,
3, 10 and 36.4 mM) for 5 days were suspended in the control
medium (glucose 36.4 mM) with 1% FBS lacking EGF, and
then plated onto a poly-L-ornithine coated Lab-Tek
Chamber SlideTM for immunocytochemistry and into a 96-
well plate for ELISA. After 7 day incubation, approximately
50% of NSCs diﬀerentiated into GFAP-immunoreactive as-
trocytes and small portion (approximately 20%) of NSCs intoTuJ1-immunoreactive neurons (Fig. 2A and B). However, the
diﬀerentiation activity was not aﬀected by low glucose ex-
posure (0, 3, or 10 mM) during the proliferation period when
evaluated by immunocytochemistry (Fig. 2B) and ELISA
(Fig. 2C).
Fig. 2. The eﬀects of low glucose in the proliferation (A)–(C) and diﬀerentiation (D)–(F) period on the diﬀerentiative activity of the cultured NSCs.
(A)–(C) NSCs dissociated from the secondary neurospheres, which had been expanded in EGF-containing medium at various concentrations of
glucose (0, 3, 10 and 36.4 mM) or (D)–(F) NSCs dissociated from the primary neurospheres, were diﬀerentiated in 1% FBS-containing medium
lacking EGF. Seven days after the treatment, the cells were ﬁxed with 4% paraformaldehyde and were processed for immunocytochemistry and the
representative immunoﬂuorescence images (A and D) and the quantiﬁed data of immunoreactive cell proportion (B and E) are shown. Otherwise,
the ﬁxed cells were processed for ELISA (C and F). The glucose concentrations during the proliferation period did not aﬀect the diﬀerentiative
activity of the NSCs, while low glucose culture during the diﬀerentiation period drastically increased the diﬀerentiation of NSCs into both neurons
and astrocytes. The asterisk indicates the signiﬁcant diﬀerence from high glucose (36.4 mM) (P < 0:05; one-way ANOVA followed by Dunnett’s
test). n ¼ 6.
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period on the diﬀerentiation of NSCs
In the next series of experiments, we examined the eﬀect of
low glucose exposure during the diﬀerentiation period on the
diﬀerentiative activity of the NSCs, because it is possible that
eﬀects of low glucose exposure are dependent on the timing of
exposure (the proliferation or diﬀerentiation period). When the
cells were diﬀerentiated in high glucose medium (36.4 mM) for7 days, diﬀerentiation of NSCs into GFAP-immunoreactive
astrocytes and TuJ1-immunoreactive neurons (Fig. 2D upper 4
photographs) was observed, although approximately 50% of
diﬀerentiated cells were astrocytes. In low glucose medium (0,
3, and 10 mM), however, NSCs diﬀerentiated into many more
neurons and astocytes than those in high glucose medium
(36.4 mM) (Fig. 2D and E). This hypoglycemia-induced fa-
cilitation of NSC diﬀerentiation was dose-dependent, namely,
N. Horie et al. / FEBS Letters 571 (2004) 237–242 241many more neurons and astrocytes were produced when the
glucose concentration was lower (Fig. 2E and F). Thus, low
glucose exposure during the diﬀerentiation period resulted in
NSCs diﬀerentiated into neurons or astrocytes, whereas low
glucose exposure during the proliferation period failed to aﬀect
the diﬀerentiative activity.4. Discussion
Our present results clearly show that exposure to low glu-
cose inﬂuences the proliferative and diﬀerentiative activity of
NSCs in an exposure-timing-dependent manner. When low
glucose was applied to NSCs during the proliferation period, it
diminished the EGF-induced proliferation, but failed to in-
ﬂuence NSC diﬀerentiation elicited by 1% FBS. On the other
hand, low glucose exposure during the diﬀerentiation period
drastically enhanced neurogenesis and astrogliogenesis from
NSCs. Thus, the glucose level was proved to be a crucial factor
for self-renewal and multipoietic activity of NSCs. To the best
of our knowledge, this is the ﬁrst report demonstrating that
glucose levels aﬀect the proliferation and diﬀerentiation of
NSCs. Because glucose concentrations in the brain as well as in
peripheral organs change dynamically under physiological and
pathological conditions such as feeding, ischemia and diabetes,
it is important to pay attention to glucose concentrations when
we evaluate the proliferation and diﬀerentiation abilities in
vivo as well as in vitro.
It has been shown that cultured NSCs derived from murine
embryonic brains are propagated by incubation in EGF-
containing and serum-free medium and begin to diﬀerentiate
into neurons and astrocytes in incubation in low serum (for
example, in 1% FBS-containing medium without EGF) [1].
By means of this NSC culture system, we were able to ex-
amine the eﬀect of low glucose on NSC activities during the
proliferation and diﬀerentiation periods separately, so that we
demonstrated that the eﬀect of low glucose on the NSC dif-
ferentiation during the proliferation period is diﬀerent from
that during the diﬀerentiation period. When NSCs were ex-
posed to low glucose during the proliferation period, it
drastically depressed NSC proliferation without aﬀecting the
subsequent diﬀerentiation elicited by 1% FBS. On the other
hand, the diﬀerentiation of NSCs into neurons and astrocytes
was signiﬁcantly facilitated when NSCs were incubated in 1%
FBS-containing medium at low glucose concentrations. These
observations suggest that low glucose concentrations diﬀer-
ently inﬂuence the proliferation and diﬀerentiation mecha-
nisms composed of a number of signal and transcriptional
factors [30], depending on the time of low glucose exposure.
From the present results, we cannot explain why low glucose
promoted NSC diﬀerentiation when applied during the dif-
ferentiation period but not during the proliferation period. It
was reported that, in PC12 cells, the glucose consumption
changes during neural diﬀerentiation by nerve growth factor
treatment [31]. It was also reported that there is a switch
in the expression of glucose transporter isoforms during
myogenic diﬀerentiation. These reports suggested that the
glucose-requirement and glucose-uptake change during cell
diﬀerentiations [32]. Therefore, the change in glucose re-
quirement and glucose-uptake during the NSC diﬀerentiation
may underlie the timing-dependent-eﬀect of hypoglycemia.Recent in vivo studies suggested that NSCs in the brain are
activated in response to cerebral ischemia, which resulted in
the production of new neurons [5–7,9,33–37]. This line of ev-
idence demonstrated that ischemia leads to NSC proliferation,
NSC migration to injury sites and NSC diﬀerentiation into
neurons. It was also reported that, in the anesthetized rat, the
extracellular concentration of glucose in the brain in situ is
maintained at a level as low as 2.4 mM, which is similar to the
glucose concentration (3 mM) used in the present study [22]. In
their report, ischemia elicited by carotid compression caused a
rapid fall in the external glucose concentration to undetectable
levels [22]. We examined the eﬀect of hypoglycemia in this
physiological concentration range, so that in vitro observa-
tions in the present study may explain in vivo observations in
their studies. Thus, the present study showed that the reduc-
tion in the glucose concentration from 3% to 0% facilitated the
NSC diﬀerentiation. Low glucose, therefore, may be attributed
to ischemia-induced NSC activations. It should be noted that,
in the present study, the facilitation of neural diﬀerentiation by
low glucose was observed within 1 week (because the diﬀer-
entiation period in the present study was 7 days). However,
there are many reports demonstrating that newborn matured
neurons appeared several weeks after ischemia in the adult
neurogenerative regions, such as SVZ [10] and dentate gyrus
[9]. On the other hand, when CRMP-4 [7] was used as a neu-
ronal marker, diﬀerentiated neurons appeared within several
days after ischemia. Thus, enhanced diﬀerentiation by low
glucose in vitro may reﬂect the early process of neural diﬀer-
entiation soon after ischemia in vivo. The pathophysiology of
ischemic brain damage is characterized by cell death in the core
region and gliogenesis and neurogenesis in the penumbra re-
gion around ischemic area. Therefore, two actions of low
glucose on the NSC activity, namely suppressed proliferation
and increased diﬀerentiation, may contribute the cell death in
the core and gliogenesis and neurogenesis in the penumbra
region, respectively. We also showed that glucose concentra-
tions higher than physiological concentrations (10 and 36.4
mM) aﬀected NSC activities: the proliferation was activated
and the diﬀerentiation was inhibited. Taken together, to acti-
vate the diﬀerentiation of NSCs in in vitro systems, we should
use medium with high glucose during the proliferation period
and medium with low glucose during the diﬀerentiation period,
although these concentrations are not physiological in intact
animals.
In addition to hypoglycemia, hypoxia is an another impor-
tant incident mediating the ischemic actions and both hypoxia
and hypoglycemia additionally or synergically may contribute
to acute and delayed neuronal death [4]. Recent studies dem-
onstrated that hypoxia enhances the proliferation of cultured
NSCs and modiﬁes their diﬀerentiative ability in in vitro
models [16,17]. In their studies, hypoxia enhanced the prolif-
eration of NSCs [16], which is in contrast to the eﬀect of hy-
poglycemia on NSCs as shown in the present study.
Furthermore, they demonstrated that exposure to lowered
oxygen during the diﬀerentiation period does not aﬀect the
neuronal diﬀerentiation from NSCs, but that exposure to
lowered oxygen during the proliferation period increases the
diﬀerentiation into neurons [16]. From their studies and our
present study, it can be concluded that the neuronal diﬀeren-
tiations are initiated only when hypoxia is applied during the
proliferation period or hypoglycemia is applied during the
diﬀerentiation period, so that the critical period of NSC
242 N. Horie et al. / FEBS Letters 571 (2004) 237–242diﬀerentiation caused by hypoxia was also proved to be dif-
ferent from that caused by hypoglycemia. Therefore, a simple
energy failure may not account for the eﬀect of ischemia on
NSC functions.
In summary, our study provides evidence that glucose is an
important regulator of neurogenesis. Higher glucose activated
the proliferation but inhibited the diﬀerentiation of NSCs,
whereas lower glucose inhibited the proliferation but activated
the diﬀerentiation of NSCs.
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